Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening

BMC Immunology

Volumn 10, Issue , 2009, Pages 53-

  Voss, Matthias ^a,b   Lettau, Marcus ^a   Janssen, Ottmar ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; PROLINE; PROTEASE NEXIN; PROTEIN KINASE; PROTEIN SH3; REGULATOR PROTEIN;

ARTICLE; GENE LIBRARY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ACTIVE TRANSPORT, CELL NUCLEUS; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CLONING, MOLECULAR; FAS LIGAND PROTEIN; HUMANS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SRC HOMOLOGY DOMAINS; VESICULAR TRANSPORT PROTEINS;

EID: 70449510239     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-53     Document Type: Article

References (40)

1. Pawson T, Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300:445-452. 10.1126/science.1083653, 12702867.
2. Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 2000, 14:231-241.
3. Mayer BJ. SH3 domains: complexity in moderation. J Cell Sci 2001, 114:1253-1263.
4. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178. 10.1016/0092-8674(93)90326-L, 7505205.
5. Janssen O, Qian J, Linkermann A, Kabelitz D. CD95 ligand-death factor and costimulatory molecule?. Cell Death Differ 2003, 10:1215-1225. 10.1038/sj.cdd.4401305, 12894217.
6. Lettau M, Paulsen M, Kabelitz D, Janssen O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr Med Chem 2008, 15:1684-1696. 10.2174/092986708784872384, 18673218.
7. Sun M, Fink PJ. A new class of reverse signaling costimulators belongs to the TNF family. J Immunol 2007, 179:4307-4312.
8. Paulsen M, Mathew B, Qian J, Lettau M, Kabelitz D, Janssen O. FasL cross-linking inhibits activation of human peripheral T cells. Int Immunol 2009, 21:587-598. 10.1093/intimm/dxp028, 19332441.
9. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O, Saftig P. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 2007, 14:1040-1049.
10. Kirkin V, Cahuzac N, Guardiola-Serrano F, Huault S, Lückerath K, Friedmann E, Novac N, Wels WS, Martoglio B, Hueber A, Zörnig M. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ 2007, 14:1678-1687. 10.1038/sj.cdd.4402175, 17557115.
11. Voss M, Lettau M, Paulsen M, Janssen O. Posttranslational regulation of Fas ligand function. Cell Commun Signal 2008, 6:11. 10.1186/1478-811X-6-11, 2647539, 19114018.
12. Hane M, Lowin B, Peitsch M, Becker K, Tschopp J. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett 1995, 373:265-268. 10.1016/0014-5793(95)01051-F, 7589480.
13. Wenzel J, Sanzenbacher R, Ghadimi M, Lewitzky M, Zhou Q, Kaplan DR, Kabelitz D, Feller SM, Janssen O. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett 2001, 509:255-262. 10.1016/S0014-5793(01)03174-X, 11741599.
14. Ghadimi MP, Sanzenbacher R, Thiede B, Wenzel J, Qian J, Plomann M, Borkhardt A, Kabelitz D, Janssen O. Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett 2002, 519:50-58. 10.1016/S0014-5793(02)02709-6, 12023017.
15. Thornhill PB, Cohn JB, Drury G, Stanford WL, Bernstein A, Desbarats J. A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells. FEBS Lett 2007, 581:4455-4462. 10.1016/j.febslet.2007.08.025, 17761170.
16. Baum W, Kirkin V, Fernandez SBM, Pick R, Lettau M, Janssen O, Zörnig M. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J Biol Chem 2005, 280:40012-40024. 10.1074/jbc.M502222200, 16204241.
17. Qian J, Chen W, Lettau M, Podda G, Zörnig M, Kabelitz D, Janssen O. Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cell Signal 2006, 18:1327-1337. 10.1016/j.cellsig.2005.10.015, 16318909.
18. Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, Bossi G, Griffiths GM. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 2007, 120:191-199. 10.1242/jcs.03315, 17164290.
19. Sun M, Ames KT, Suzuki I, Fink PJ. The cytoplasmic domain of Fas ligand costimulates TCR signals. J Immunol 2006, 177:1481-1491.
20. Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D, Janssen O. The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci USA 2006, 103:5911-5916. 10.1073/pnas.0508562103, 1458672, 16595635.
21. Bolen JB, Brugge JS. Leukocyte protein tyrosine kinases: potential targets for drug discovery. Annu Rev Immunol 1997, 15:371-404. 10.1146/annurev.immunol.15.1.371, 9143693.
22. Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 2005, 23:549-600. 10.1146/annurev.immunol.22.012703.104743, 15771581.
23. Lettau M, Schmidt H, Kabelitz D, Janssen O. Secretory lysosomes and their cargo in T and NK cells. Immunol Lett 2007, 108:10-19. 10.1016/j.imlet.2006.10.001, 17097742.
24. Cullen PJ. Endosomal sorting and signalling: an emerging role for sorting nexins. Nat Rev Mol Cell Biol 2008, 9:574-582. 10.1038/nrm2427, 18523436.
25. Lundmark R, Carlsson SR. SNX9 - a prelude to vesicle release. J Cell Sci 2009, 122:5-11. 10.1242/jcs.037135, 19092055.
26. Reutens AT, Begley CG. Endophilin-1: a multifunctional protein. Int J Biochem Cell Biol 2002, 34:1173-1177. 10.1016/S1357-2725(02)00063-8, 12127567.
27. Schöbel S, Neumann S, Hertweck M, Dislich B, Kuhn P, Kremmer E, Seed B, Baumeister R, Haass C, Lichtenthaler SF. A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein. J Biol Chem 2008, 283:14257-14268. 10.1074/jbc.M801531200, 18353773.
28. Pucharcos C, Estivill X, de la Luna S. Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis. FEBS Letters 2000, 478:43-51. 10.1016/S0014-5793(00)01793-2, 10922467.
29. McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA. The intersectin 2 adaptor links Wiskott Aldrich Syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med 2001, 194:1777-1787. 10.1084/jem.194.12.1777, 2193569, 11748279.
30. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, Tang H, Wen L, Brady-Kalnay SM, Mei L, Wu JY, Xiong WC, Rao Y. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001, 107:209-221. 10.1016/S0092-8674(01)00530-X, 11672528.
31. Furukawa Y, Kawasoe T, Daigo Y, Nishiwaki T, Ishiguro H, Takahashi M, Kitayama J, Nakamura Y. Isolation of a novel human gene, ARHGAP9, encoding a rho-GTPase activating protein. Biochem Biophys Res Commun 2001, 284:643-649. 10.1006/bbrc.2001.5022, 11396949.
32. Ang BK, Lim CY, Koh SS, Sivakumar N, Taib S, Lim KB, Ahmed S, Rajagopal G, Ong SH. ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain binding. J Mol Signal 2007, 2:1. 10.1186/1750-2187-2-1, 1805438, 17284314.
33. Bossi G, Booth S, Clark R, Davis EG, Liesner R, Richards K, Starcevic M, Stinchcombe J, Trambas C, Dell'Angelica EC, Griffiths GM. Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XV. Traffic 2005, 6:243-251. 10.1111/j.1600-0854.2005.00264.x, 15702992.
34. He J, Ostergaard HL. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 2007, 179:2339-2348.
35. Kassahn D, Nachbur U, Conus S, Micheau O, Schneider P, Simon H, Brunner T. Distinct requirements for activation-induced cell surface expression of preformed Fas/CD95 ligand and cytolytic granule markers in T cells. Cell Death Differ 2009, 16:115-124. 10.1038/cdd.2008.133, 19079288.
36. Kim DJ, Kim SH, Lim CS, Choi KY, Park CS, Sung BH, Yeo MG, Chang S, Kim J, Song WK. Interaction of SPIN90 with the Arp2/3 complex mediates lamellipodia and actin comet tail formation. J Biol Chem 2006, 281:617-625. 10.1074/jbc.M504450200, 16253999.
37. Buschman M, Bromann P, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA. The Novel Adaptor Protein Tks4 (SH3PXD2B) Is Required for Functional Podosome Formation. Mol Biol Cell 2009, 20:1302-1311. 10.1091/mbc.E08-09-0949, 2649273, 19144821.
38. Peterson EJ. The TCR ADAPts to integrin-mediated cell adhesion. Immunol Rev 2003, 192:113-121. 10.1034/j.1600-065X.2003.00026.x, 12670399.
39. Togni M, Lindquist J, Gerber A, Kolsch U, Hamm-Baarke A, Kliche S, Schraven B. The role of adaptor proteins in lymphocyte activation. Mol Immunol 2004, 41:615-630. 10.1016/j.molimm.2004.04.009, 15219999.
40. Wang H, Rudd CE. SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion. Trends Cell Biol 2008, 18:486-493. 10.1016/j.tcb.2008.07.005, 18760924.